Navigation Links
Study shows high rates, rising costs of alcohol/drug disorders in hospitalized patients
Date:6/25/2008

Philadelphia, PA, June 25, 2007 Fourteen percent of patients admitted to the hospital have alcohol/drug abuse and addiction (ADAA) disorders, costs for which have risen sharply in recent years, according to a study in the June issue of the Journal of Substance Abuse Treatment (JSAT).

"Our results demonstrated the high prevalence of hospital admissions with co-occurring ADAA and the striking financial costs placed on the hospital, government programs, and insurers," write Patricia B. Santora, Ph.D., and Heidi E. Hutton, Ph.D., of The Johns Hopkins University School of Medicine, Baltimore.

The researchers analyzed 43,000 patients with ADAA disordersmainly in addition to other medical diagnoseswho were admitted to Johns Hopkins Hospital from 1994 to 2002. Patients with ADAA accounted for 13.7 percent of all hospital admissions during that time. About one-half of the patients used a combination of two or more drugs, one-fourth used alcohol only, and the rest used opioids (like heroin) or cocaine only. The number of opioid abusers rose sharply during the period studied, reflecting the recent resurgence of heroin in Baltimore. Patient characteristics differed by insurance status. In particular, patients on Medicaid/Medicare and uninsured patients were more likely to have drug addictions, while patients with private insurance were more likely to abuse alcohol only.

Adjusted for inflation, overall hospital costs for patients with ADAA disorders increased by 134 percent from 1994 to 2002. Medicaid/Medicare patients accounted for 70 percent of patients and 70 percent of the costs. Although costs increased for all types of ADAA disorders, the greatest increase was seen for opioid abuse482 percent from 1994 to 2002. However, patients with alcohol abuse/addiction accounted for the highest proportion of costs.

Only about one percent of patients had an ADAA disorder as their only diagnosisthe remaining 99 percent had other medical problems as well. "[T]hus most of these escalating costs were for treatment the medical illnesses (primary diagnosis of admissions with co-occurring ADAA," the researchers write.

The results lend insights into the scope and costs of ADAA disorders in hospitalized patients. "Understanding ADAA's broad impact has implications for delivering better health care, decreasing ADAA-related illnesses and mortality, and reducing health care costs," the researchers write. Since alcohol and drug abuse are major contributors to leading causes of deathheart disease, cancer, and strokeinvesting appropriate resources to ADAA treatment could reduce the costs of treating associated medical disorders.

Drs. Santora and Hutton emphasize the need for health care providers to provide screening and intervention services for hospitalized patients with ADAAjust as they do for patients with other chronic illnesses, such as diabetes or high blood pressure. This is especially important because drug or alcohol abuse increases the likelihood that patients will not follow their prescribed care, thus increasing the risk of poor treatment outcomes and higher costs. The researchers hope their results will serve as a baseline for evaluating efforts to manage ADAA in hospitalized patients, and to control their impact on health care costs.


'/>"/>

Contact: Jayne M. Dawkins
ja.dawkins@elsevier.com
215-239-3674
Elsevier
Source:Eurekalert

Related medicine news :

1. Study uncovers how Ritalin works in brain to boost cognition, focus attention
2. Cosmetic surgery procedures to exceed 55 million in 2015, ASPS study predicts
3. HealthGrades releases Fifth Annual Womens Health in American Hospitals study
4. Study further defines potential role of fish-based fatty acids in resolving, preventing asthma
5. Study evaluates factors associated with racial disparities in colon cancer screening
6. Study in Circulation provides detail on how low blood flow promotes vascular disease
7. Study shows that chronic grief activates pleasure areas of the brain
8. Researchers seek children for a study of antibiotics for a urinary tract disorder
9. NIH funds highway pollution and health study in Boston, Somerville
10. Study links vitamin D to colon cancer survival
11. Study: Medicare Competitive Bidding Program Could Impede Seniors Access to Diabetes Testing Supplies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... PLAINS, N.Y., and JENNERSVILLE, Pa. (PRWEB) , ... ... ... to announce that Penn Medicine Southern Chester County, a Property owned by an ... The $23 million, 72,000 square foot Penn Medicine Southern Chester County ambulatory care ...
(Date:12/8/2016)... Boston (PRWEB) , ... December 08, 2016 , ... ... shareholders with global law firm Greenberg Traurig, LLP, will speak at DeviceTalks West, Dec. ... sponsor of the DeviceTalks series, and attorneys from the firm’s global Life Sciences & ...
(Date:12/8/2016)... N.J. (PRWEB) , ... December 08, 2016 , ... ... delivery technologies and development solutions for drugs, biologics and consumer health products, today ... PSCI was set up in 2006 as a non-profit organization to unite pharmaceutical ...
(Date:12/8/2016)... Peachtree City, Ga (PRWEB) , ... December 08, ... ... and moving as soon after surgery as possible. With this in mind, SIGVARIS ... vein thrombosis (DVT or blood clot) during bed rest and provide the benefits ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... services from offices headquartered in Hamilton County, is embarking on a charity drive ... specializes in finding new homes for orphaned or neglected senior dogs in the ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... ANGELES , Dec. 8, 2016  Hanson ... manufacturing of dissolution testing and diffusion testing instruments ... been acquired by Teledyne Instruments, Inc. ("Teledyne"). The ... long-proven line of precision testing instruments, as well ... accelerating development of new products and services. ...
(Date:12/8/2016)... 2016  Haemonetics Corporation (NYSE: HAE ) has ... an innovative software suite designed to help customers drive efficiency ... of NextGen DMS 4 improves core features and introduces innovations ... liter of plasma collected, enhancing quality and regulatory compliance and ... ...
(Date:12/8/2016)... Inc . has announced regulatory approval by CFDA and product launch in ... (GERD). Continue Reading ... ... by Professor Jun Liu, Director of Endoscopy at Wuhan Union Hospital ... "We are very pleased that Mederi products are now available in ...
Breaking Medicine Technology: